EORTC, CTI, and IRROG collaboration opens new opportunities in Ireland
12 Dec 2022
EORTC 1634-Brain Tumour Group trial in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I) receives support from Gateway for Cancer Research℠
27 Jul 2021
Surviving glioblastoma? EORTC Brain Tumour Group explores the factors that contribute to long-term survival
23 Mar 2021
PRESS RELEASE: Advocacy Organizations and Professional Societies from Across the Globe Unite on Brain Tumour Patients’ Charter of Rights
16 Jul 2020
Another successful EORTC rare tumour trial: latest CATNON results presented at ASCO
18 Sep 2019
New trial in Glioblastoma – step forward in the battle against an aggressive and incurable disease
13 Dec 2018
The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors
4 Dec 2018
Interim Results of the CATNON Study – the Effects of Temozolomide
31 Aug 2017
